Provided by Tiger Trade Technology Pte. Ltd.

Korro Bio, Inc.

10.40
-0.5100-4.67%
Post-market: 10.400.00000.00%16:10 EDT
Volume:127.09K
Turnover:1.33M
Market Cap:149.99M
PE:-0.83
High:10.87
Open:10.80
Low:10.25
Close:10.91
52wk High:55.89
52wk Low:5.20
Shares:14.42M
Float Shares:10.20M
Volume Ratio:0.78
T/O Rate:1.25%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-12.4806
EPS(LYR):-12.4806
ROE:-110.70%
ROA:-32.14%
PB:2.92
PE(LYR):-0.83

Loading ...

Korro Bio Inc. publishes corporate presentation on RNA editing genetic medicines and pipeline milestones

Reuters
·
Mar 20

Korro Bio Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
Mar 16

Korro Bio files to sell 7.65M shares of common stock for holders

TIPRANKS
·
Mar 14

Korro Bio Stock Gains After Tough 2025 - New Drug Candidate, Analyst Upgrades Boost Outlook

Benzinga
·
Mar 14

Korro Bio Is Maintained at Overweight by Cantor Fitzgerald

Dow Jones
·
Mar 13

Korro Bio price target raised to $22 from $21 at Cantor Fitzgerald

TIPRANKS
·
Mar 13

Analysts Offer Insights on Healthcare Companies: Korro Bio (KRRO), Sagimet Biosciences, Inc. Class A (SGMT) and Bristol-Myers Squibb (BMY)

TIPRANKS
·
Mar 13

Analysts Are Bullish on These Healthcare Stocks: Korro Bio (KRRO), Health Catalyst (HCAT)

TIPRANKS
·
Mar 13

Korro Bio Q4 EPS $(5.32) Misses $(2.05) Estimate, Sales $1.290M Beat $670.000K Estimate

Benzinga
·
Mar 13

Korro Bio Enters Subscription Agreement for $85 Million Private Placement

MT Newswires Live
·
Mar 09

Korro Bio Inc - Proceeds Expected to Extend Cash Runway Into Second Half of 2028

THOMSON REUTERS
·
Mar 09

Korro Bio Inc - Pipe Financing Led by Venrock Healthcare Capital Partners

THOMSON REUTERS
·
Mar 09

Press Release: Korro Announces Oversubscribed $85 Million Private Placement

Dow Jones
·
Mar 09

Korro Bio CEO Ram Aiyar to Present at TD Cowen 46th Annual Health Care Conference

Reuters
·
Feb 26

Korro Bio Raised to Buy From Hold by Clear Street

Dow Jones
·
Feb 19

Korro Bio Shares Rise After William Blair Upgrade

MT Newswires Live
·
Feb 18

William Blair Upgrades Korro Bio to Outperform From Market Perform

MT Newswires Live
·
Feb 17

Analysts’ Top Healthcare Picks: Korro Bio (KRRO), Alto Neuroscience, Inc. (ANRO)

TIPRANKS
·
Feb 17

Analysts Offer Insights on Healthcare Companies: Regeneron (REGN), Korro Bio (KRRO) and AstraZeneca (AZN)

TIPRANKS
·
Feb 01

Korro Bio Shares Rise After Piper Sandler, HC Wainwright Upgrades

MT Newswires Live
·
Jan 30